Use of Slow-Release Oral Morphine for the Treatment of Opioid Dependence

Abstract

The high study retention rate implies a good acceptance of slow-release acting oral morphine. However, randomised, double-blind, double-dummy studies with a longer investigational period are needed to meet criteria for evidence-based medicine.